An ongoing Phase I/II clinical trial is evaluating VX-880 as a treatment for type 1 diabetes (T1D). Image courtesy of Ahmet Misirligul/Shutterstock. Vertex Pharmaceuticals The company announced positive data from …
Copyright MatchingDonors.com © 2026 All rights reserved.
Daily Diabetes News is published by MatchingDonors.com.